KaloBios Pharmaceuticals Inc. said it has just signed a governance agreement with former Chief Executive Officer Martin Shkreli that includes provisions to repurchase his shares and restrict his shareholder actions, Bloomberg News reported yesterday. The agreement applies to all common stock Shkreli holds or controls in the company, Brisbane, Calif.-based KaloBios said today. KaloBios filed for bankruptcy in December, after Shkreli was arrested on fraud charges related to other businesses in which he was involved. He has denied the allegations. The company has the right to purchase any or all of Shkreli’s shares beginning 61 days after June 30, when it effectively emerged from bankruptcy proceedings, according to the company.
